Clearmind Medicine Inc. (CMND) Stock
Healthcare · Biotechnology · CA
$3.23
-18.84%
Last updated Jun 19, 2026 00:00 UTC
CMND Key Statistics
Market Cap$441,408.57
P/E (TTM)-0.10
P/S (TTM)—
P/B (TTM)0.46
Revenue (TTM)$0.00
EPS (TTM)$-32.14
Dividend Yield—
ROE (TTM)-211.90%
Net Margin0.00%
Gross Margin0.00%
52W High$15.20
52W Low$0.59
Analyst View—
Price Target—
Employees4
Volume228,617
About Clearmind Medicine Inc.
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
CEO: Adi Zuloff-Shani. Company website
See CMND live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open CMND in Terminal See plans